Local Institution - Germany — No City Provided, New Jersey

Local Institution - Germany is a clinical research site located in No City Provided, New Jersey, United States 00000.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - Germany has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Multiple Myeloma.

Sponsors: Celgene, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in No City Provided

Browse all research sites in New Jersey · View every site in No City Provided

• Local Institution - Italy
• Local Institution - France
• Local Institution - Sweden
• Local Institution - Luxembourg
• Local Institution - Spain
• Local Institution - Greece
• Local Institution - United Kingdom
• Local Institution - Canada
• Local Institution - USA
• Local Institution - UK
• Local Institution - Norway

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - Germany?

Local Institution - Germany has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - Germany conducted?

Local Institution - Germany has 2 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, Multiple Myeloma.

Is Local Institution - Germany accredited by Crixeo Clinical Trials?

Local Institution - Germany has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - Germany?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.